Plante Moran Financial Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Plante Moran Financial Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.66K	Buy	+49	New	+$1.63K	﹤0.01%	779
2020 Q1	–	Sell	-137	Closed	-$1K	–	836
2019 Q4	$1K	Hold	137	–	–	﹤0.01%	730
2019 Q3	$1K	Hold	137	–	–	﹤0.01%	825
2019 Q2	$1K	Hold	137	–	–	﹤0.01%	765
2019 Q1	$2K	Hold	137	–	–	﹤0.01%	725
2018 Q4	$2K	Hold	137	–	–	﹤0.01%	750
2018 Q3	$3K	Hold	137	–	–	﹤0.01%	658
2018 Q2	$3K	Sell	137 -85	-38%	-$1.73K	﹤0.01%	690
2018 Q1	$4K	Buy	222 +85	+62%	+$1.66K	﹤0.01%	763
2017 Q4	$3K	Hold	137	–	–	﹤0.01%	767
2017 Q3	$2K	Hold	137	–	–	﹤0.01%	736
2017 Q2	$5K	Hold	137	–	–	﹤0.01%	670
2017 Q1	$4K	Sell	137 -720	-84%	-$24.6K	﹤0.01%	736
2016 Q4	$31K	Buy	857 +137	+19%	+$5.47K	0.02%	409
2016 Q3	$33K	Sell	720 -72	-9%	-$3.76K	0.02%	396
2016 Q2	$40K	Buy	792 +677	+589%	+$36K	0.03%	326
2016 Q1	$6K	Buy	+115	New	+$6.75K	﹤0.01%	565
2014 Q3	–	Sell	-250	Closed	-$13K	–	849
2014 Q2	$13K	Hold	250	–	–	0.01%	463
2014 Q1	$13K	Sell	250 -83	-25%	-$3.84K	0.01%	314
2013 Q4	$13K	Buy	333 +83	+33%	+$3.27K	0.01%	410
2013 Q3	$9K	Hold	250	–	–	0.01%	404
2013 Q2	$10K	Buy	+250	New	+$9.74K	0.01%	352

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Plante Moran Financial Advisors's TEVA Position: Q2 2026 in Review

Plante Moran Financial Advisors opened a new position in Teva Pharmaceutical Industries Limited (TEVA) in Q2 2026: 49 shares worth $1.66K. The stake represents ﹤0.01% of the portfolio and ranks #779 among its holdings. This is a return to the name: Plante Moran Financial Advisors previously reported a position in TEVA as recently as Q4 2019.

Plante Moran Financial Advisors first reported a position in TEVA in Q2 2013 and has held it in 22 quarters since. The position peaked at $40K in Q2 2016. 677 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Plante Moran Financial Advisors held 49 shares of Teva Pharmaceutical Industries Limited worth $1.66K as of Q2 2026.
Teva Pharmaceutical Industries Limited was a new Plante Moran Financial Advisors position in Q2 2026.
Teva Pharmaceutical Industries Limited made up ﹤0.01% of Plante Moran Financial Advisors's portfolio in Q2 2026, its #779 holding.
Plante Moran Financial Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and has held it in 22 quarters since.
Plante Moran Financial Advisors's Teva Pharmaceutical Industries Limited position peaked at $40K in Q2 2016.
677 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Plante Moran Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.